Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer

Phase 3 Completed 416 enrolled King Faisal Specialist Hospital & Research Center

RandomizedSingle-groupOpen-labelTreatment

Summary

This is a phase III trial of LHRH analog administration during chemotherapy to reduce ovarian failure following chemotherapy in early stage, hormone-receptor negative breast cancer.

Timeline

Start: 2009-11
Primary completion: 2012-11
Completion: 2012-11

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Goserelin	Other / unclassified	—	—
Comparator	Cyclophosphamide	Other / unclassified	—	—

Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer

Summary

Timeline

Drugs

Indications